LivaNova (LIVN) Net Cash Flow Growth (1y) (2017 - 2026)
LivaNova (LIVN) Net Cash Flow Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn | -562.77% |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn | 2,827.78% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn | -395.56% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 168.38% |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn | -103.49% |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn | -114.85% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -215.59% |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn | -54.17% |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | 85.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 85.95% |
| Mar 31, 2026 | -1,149.78% |
| Dec 31, 2025 | -116.65% |
| Sep 30, 2025 | 80.28% |
| Jun 30, 2025 | -919.53% |
| Mar 31, 2025 | -78.13% |
| Dec 31, 2024 | 75.41% |
| Sep 30, 2024 | 667.20% |
| Jun 30, 2024 | 65.62% |
| Mar 31, 2024 | 909.53% |
| Dec 31, 2023 | 504.00% |
| Sep 30, 2023 | -96.31% |
| Jun 30, 2023 | 134.92% |
| Mar 31, 2023 | -98.28% |
| Dec 31, 2022 | -77.05% |
| Sep 30, 2022 | 170.42% |
| Jun 30, 2022 | -142.79% |
| Mar 31, 2022 | 18,077.59% |
| Dec 31, 2021 | 13.91% |
| Sep 30, 2021 | -2,429.79% |